Trulieve Cannabis Corp. (TCNNF)
OTCMKTS · Delayed Price · Currency is USD
7.21
+0.30 (4.34%)
Feb 2, 2026, 4:00 PM EST
Trulieve Cannabis Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 1,189 | 1,186 | 1,129 | 1,218 | 931.93 | 521.53 | |
Revenue Growth (YoY) | 1.44% | 5.07% | -7.31% | 30.72% | 78.69% | 106.29% |
Cost of Revenue | 466.16 | 470.75 | 540.57 | 529.1 | 324.17 | 134.16 |
Gross Profit | 723.02 | 715.75 | 588.63 | 689.13 | 607.76 | 387.37 |
Selling, General & Admin | 476.84 | 510.45 | 386.16 | 446.83 | 295.53 | 150.73 |
Operating Expenses | 593.7 | 623.26 | 495.99 | 563.22 | 341.32 | 163.33 |
Operating Income | 129.32 | 92.49 | 92.64 | 125.91 | 266.44 | 224.05 |
Interest Expense | -63.39 | -62.19 | -81.57 | -73.42 | -29.12 | -20.24 |
Interest & Investment Income | 14.28 | 14.68 | 6.16 | 1.63 | 0.21 | - |
Other Non Operating Income (Expenses) | -4.77 | -7.55 | 6.54 | 2.39 | 1.11 | -40.62 |
EBT Excluding Unusual Items | 75.45 | 37.42 | 23.78 | 56.51 | 238.64 | 163.19 |
Merger & Restructuring Charges | - | - | - | -0.2 | -57.02 | -5.68 |
Impairment of Goodwill | - | - | -307.59 | - | - | - |
Gain (Loss) on Sale of Assets | -0.5 | -0.5 | -5.7 | -17.8 | -1.73 | - |
Asset Writedown | -7.72 | -2.61 | -0.96 | -57.75 | -3.64 | -0.06 |
Other Unusual Items | - | - | 5.94 | - | - | - |
Pretax Income | 75.63 | 42.71 | -284.54 | -19.24 | 176.25 | 157.45 |
Income Tax Expense | 207.79 | 197.59 | 151.36 | 163.38 | 145.72 | 94.45 |
Earnings From Continuing Operations | -132.16 | -154.88 | -435.9 | -182.62 | 30.53 | 63 |
Earnings From Discontinued Operations | -8.06 | -5.7 | -96.05 | -67.44 | -13.08 | - |
Net Income to Company | -140.22 | -160.58 | -531.94 | -250.06 | 17.45 | 63 |
Minority Interest in Earnings | 6.95 | 5.47 | 5.15 | 3.99 | 0.59 | - |
Net Income | -133.27 | -155.11 | -526.8 | -246.06 | 18.03 | 63 |
Net Income to Common | -124.26 | -155.11 | -526.8 | -246.06 | 18.03 | 63 |
Net Income Growth | - | - | - | - | -71.38% | 18.65% |
Shares Outstanding (Basic) | 191 | 190 | 189 | 188 | 139 | 114 |
Shares Outstanding (Diluted) | 191 | 190 | 189 | 188 | 147 | 118 |
Shares Change (YoY) | 0.60% | 0.54% | 0.52% | 28.10% | 24.03% | 2.61% |
EPS (Basic) | -0.65 | -0.82 | -2.79 | -1.31 | 0.13 | 0.55 |
EPS (Diluted) | -0.65 | -0.82 | -2.79 | -1.31 | 0.12 | 0.53 |
EPS Growth | - | - | - | - | -77.19% | 15.22% |
Free Cash Flow | 160.8 | 149.18 | 166.86 | -161.32 | -297.23 | -46.22 |
Free Cash Flow Per Share | 0.84 | 0.79 | 0.88 | -0.86 | -2.02 | -0.39 |
Gross Margin | 60.80% | 60.32% | 52.13% | 56.57% | 65.22% | 74.28% |
Operating Margin | 10.88% | 7.80% | 8.20% | 10.34% | 28.59% | 42.96% |
Profit Margin | -10.45% | -13.07% | -46.65% | -20.20% | 1.93% | 12.08% |
Free Cash Flow Margin | 13.52% | 12.57% | 14.78% | -13.24% | -31.89% | -8.86% |
EBITDA | 301.17 | 258.86 | 263.3 | 300.23 | 338.61 | 253.14 |
EBITDA Margin | 25.33% | 21.82% | 23.32% | 24.64% | 36.33% | 48.54% |
D&A For EBITDA | 171.85 | 166.37 | 170.66 | 174.32 | 72.17 | 29.1 |
EBIT | 129.32 | 92.49 | 92.64 | 125.91 | 266.44 | 224.05 |
EBIT Margin | 10.88% | 7.80% | 8.20% | 10.34% | 28.59% | 42.96% |
Effective Tax Rate | 274.75% | 462.59% | - | - | 82.68% | 59.99% |
Advertising Expenses | - | 22.9 | 12.1 | 8.2 | 7.5 | 2.1 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.